Treatment of DKA in Queen Sirikit National Institute of Child Health according to Thai society for pediatric endocrinology guideline 2020

Authors

  • Piriya Chantrathammachart Pediatric department, Queen Sirikit National Institute of Child Health, Thailand
  • Sangkhae Boonrod Pediatric department, Queen Sirikit National Institute of Child Health, Thailand

DOI:

https://doi.org/10.14456/jemst.2021.17

Keywords:

diabetes ketoacidosis (DKA), cerebral edema, hyperchloremic metabolic acidosis, persistent acidosis

Abstract

Diabetic ketoacidosis (DKA) is a life-threatening condition in diabetes patients. It should be immediately diagnosed and managed to prevent morbidity and mortality. Management guideline for diabetic ketoacidosis and hyperglycemic hyperosmolar state in children and adolescent 2020 from Thai Society for Pediatric Endocrinology was the main protocol at Queen Sirikit National Institue of Child Health since January 2020. This study aimed to assess DKA treatment outcome and complications among children and adolescent patients at Queen Sirikit National Institue of Child Health. It was conducted as a retrospective descriptive study in patients who were admitted as DKA cases from January 2020 to June 2021. The collected data were patient characteristics, clinical manifestation, investigations, treatment methods and complications. Data analysis was presented in percentage, mean, median and standard deviation. As for the results, a total of 37 reviewed charts were collected. Most of the patients were diagnosed as severe DKA (73%). There were 90% of type 1 diabetes and 54% of newly diagnosed diabetes. The common chief complaints were dehydration (92%), Kussmual breathing (76%), and vomiting (73%). Infection was the most common precipitating factor for overall DKA patients (78%). In known diabetic patients, lack of insulin injection was the main factor (70%). Ninety-two percent of DKA patients were started the treatment at emergency room and received initial fluid management with 0.9%NaCl for 1-2 hours. The average time to start continuous insulin infusion was 1.4 hour. Insulin dose 0.1unit/kg/hour was started in 70% of patients. The mean duration to get rid of DKA was 14.8±5.8 hours. Hypokalemia was the most common complication (62%). Other complications were hyperchloremic metabolis acidosis, persistent acidosis, acute kidney injury, and cerebral edema. No mortality observed in this study. In conclusion, the common precipitating factors for DKA were infection and lack of insulin injection, Therefore diabetic self-management education (DSME) may have benefit for preventing DKA episode. The 2020 Thai Society for Pediatric Endocrinology guideline was effective for the treatment of DKA in this study. Closed monitoring and awareness for complications such as hypokalemia were recommended.

References

สมาคมต่อมไร้ท่อเด็กและวัยรุ่นไทย. แนวทางการรักษาภาวะ diabetic ketoacidosis และ hyperglycemic hyperosmolar state ในเด็กและวัยรุ่น 2563 [อินเทอร์เน็ต]. 2563 [สืบค้น เมื่อ 8 มิ.ย. 2564]. แหล่งข้อมูล: http://www.thaipediatrics.org/Media/media-20200122141138.pdf

ชมรมต่อมไร้ท่อเด็กและวัยรุ่นแห่งประเทศไทย. แนวทางการ รักษาภาวะ diabetic ketoacidosis และ hyperglycemic hyperosmolar state ในเด็กและวัยรุ่น 2560 [อินเทอร์เน็ต]. 2560 [สืบค้นเมื่อ 8 มิ.ย. 2564]. แหล่งข้อมูล: http:// 110.164.147.155/kmhealth_new/Documment/diabetes/knowledge/9.pd

Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018;19 (Suppl 27):155-77.

อาภาพร แต้นวกุล. การดูแลรักษาตามแนวทางการดูแลภาวะ ดีเคเอในเด็กและวัยรุ่น [วิทยานิพนธ์เพื่อวุฒิบัตรแสดงความรู้ความชำนาญในการประกอบวิชาชีพเวชกรรมสาขากุมาร เวชศาสตร์ของแพทยสภา]. กรุงเทพมหานคร: สถาบันสุขภาพเด็กแห่งชาติมหาราชินี; 2560. 35 หน้า.

Al-Obaidi AH, Alidrisi HA, Mansour AA. Precipitating factors for diabetic ketoacidosis among patients with type 1 diabetes mellitus: the effect of socioeconomic status. Int J Diabetes Metab 2019;25:52-60.

Kuppermann N, Ghetti S, Schunk JE, Stoner MJ, Rewers A, McManemy JK, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Eng J Med 2018;378:2275-87.

Williams V, Jayashree M, Nallasamy K, Dayal D, Rawat A. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a dou ble-blind randomized controlled trial. Crit Care 2020; 24:1.

Nallasamy K, Jayashree M, Singhi S, Bansal A. Lowdose vs standard-dose insulin in pediatric diabetic ketoacidosis: a randomized clinical trial. JAMA Pediatr 2014; 168:999-1005.

Lee LK, Ko CH, Lee CY, Hung CN, Fong NC, Yiu WL. Prevalence and potential risk factors of hypokalemia in pediatric patients with diabetic ketoacidosis. Int J Pediatr Endocrinol 2015; 2015(Suppl 1):8.

Rewers A, Kuppermann N, Stoner MJ, Garro A, Bennett JE, Quayle KS, et al. Effect of fluid rehydration strategy on correction of acidosis and electrolyte abnormalities in children with diabetic ketoacidosis. Diabetes Care 2021; 44:2061-8.

Toledo I, Wainsztein R, Mannucci C, Ferraro M, Ferreira J, Balestracci A. Impact of the hyperchloremic component of metabolic acidosis on the patient’s hydration status and the treatment of diabetic ketoacidosis. Arch Argent Pediatr 2018;116:365-70

Downloads

Published

2021-12-31

How to Cite

1.
Chantrathammachart P, Boonrod S. Treatment of DKA in Queen Sirikit National Institute of Child Health according to Thai society for pediatric endocrinology guideline 2020 . Jemst-01JHS [internet]. 2021 Dec. 31 [cited 2025 Dec. 12];1(2):171-83. available from: https://he03.tci-thaijo.org/index.php/Jemst-01JHS/article/view/98

Issue

Section

Original Article